Presentation TCT 2015

FIH Data Review Regarding Degree and Duration of DCB Efficacy in De Novo Lesions: Is There a Class Effect?

Presenter: Gunnar Tepe

October 12, 2015

REGISTER for free or LOG IN to view this content

FIH Data Review Regarding Degree and Duration of DCB Efficacy in De Novo Lesions: Is There a Class Effect?

Presentation

TCT 2015

Up Next

Presentation TCT 2015

Essentials of Quality and Compliance in Research

Presenter: Kate Dalton

October 11, 2015

More slides +

Presentation TCT 2015

PAR-1 Antagonists and P2Y12 Inhibitors: What Are the Data and the Place of These Medications in the PAD Population (for Secondary Cardiovascular Prevention and PAD Itself)?

Presenter: Ori Ben-Yehuda

October 11, 2015

Presentation TCT 2015

Debate: Is CREST-2 a Worthwhile Use of Precious Resources? The CREST-2 Trial Is the Right Trial at the Right Time!

Presenter: Gary S. Roubin

October 14, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.